Skip to main content
PMC home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;20(1):61–66. doi: 10.1002/clc.4960200113

Relation of iodine‐123 metaiodobenzylguanidine myocardial scintigraphy to endomyocardial biopsy findings in patients with dilated cardiomyopathy

Katsutoshi Murata 1, Shozo Kusachi 1,✉, Takashi Murakami 1, Kunio Nogami 1, Masahiro Murakami 1, Satoshi Hirohata 1, Youkou Tominaga 1, Issei Komatsubara 1, Takao Tsuji 1
PMCID: PMC6656273  PMID: 8994740

Abstract

Background: Iodine‐123 metaiodobenzylguanidine (123I‐MIBG) concentrates in adrenergic neurons and has been developed for evaluation of the sympathetic nervous system. Recent studies have demonstrated that the normal heart is clearly visualized by 123I‐MIBG cardiac scintigraphy, whereas abnormal 123I‐MIBG myocardial uptake and washout have been demonstrated in patients after myocardial infarction and in patients with congestive cardiomyopathy, long QT syndrome, and ventricular tachycardia.

Hypothesis: Based on evidence from recent studies, it can be hypothesized that 123I‐MIBG uptake is related to histopathologic changes in the myocardium.

Methods: The relation of 123I‐MIBG uptake to the histologic findings for the heart was studied in 24 patients with dilated cardiomyopathy (DCM). The study group did not include patients with complicating disorders that primarily affect the adrenergic nervous system. The 123I‐MIBG uptake was visually assigned one of four grades using the two criteria of the mean score for six regional uptake grades (mean score) and the global score obtained by visual evaluation of the entire image (global score). The 123I‐MIBG uptake score was also determined for the region at which the biopsy specimen was obtained (biopsy region score). The histologic findings were evaluated by assigning one of four grades for each of the following five factors: myocyte hypertrophy, myocardial fibrotic change, myocyte degeneration and necrosis, mononuclear cell infiltration, and myocyte disarray. The sum for all grades was defined as the total score, and the global score was also assigned to the overall histologic findings.

Results: All of the global, mean, and biopsy region scores for 123I‐MIBG uptake correlated significantly with the global and total scores for the histologic findings. Among the histologic factors, myocyte degeneration showed score correlated with all global, mean, and biopsy region scores for the uptake. Myocyte hypertrophy was associated weakly with the 123I‐MIBG uptake scores.

Conclusion: These results indicate that 123I‐MIBG uptake imaging is associated with histopathologic abnormalities in patients with DCM.

Keywords: dilated cardiomyopathy, histopathology, degeneration, fibrosis, beta receptor, nuclear medicine

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

References

  • 289. Sisson JC, Wieland DM, Sherman P, Mangner TJ, Tobes MC, Jacques S: Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 1987: 28: 1620–1624 [PubMed] [Google Scholar]
  • 290. Wieland DM, Brown LE, Rogers WL, Worthington KC, Wu J‐L, Clinthorne NH, Otto CA, Swanson DP, Beierwaltes WH: Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 1981; 22: 22–31 [PubMed] [Google Scholar]
  • 291. Kline RC, Swanson DP, Wieland DM, Thrall JH, Gross MD, Pitt B, Beierwaltes WH: Myocardial imaging in man with 1–123 mataiodobenzylguanidine. J Nucl Med 1981; 22: 129–132 [PubMed] [Google Scholar]
  • 292. Sisson JC, Shapiro B, Meyers L, Mallette S, Mangner TJ, Wieland DM, Glowniak JV, Sherman P, Beierwaltes WH: Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 1987; 28: 1625–1636 [PubMed] [Google Scholar]
  • 293. Stanton MS, Tuli MM, Radtke NL, Heger JJ, Miles WM, Mock BH, Burt RW, Wellman HN, Zipes DP: Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using 1–123‐metaiodobenzylguanidine. J Am Coll Cardiol 1989; 14: 1519–1526 [DOI] [PubMed] [Google Scholar]
  • 294. McGhie AI, Corbett JR, Akers MS, Padmakur K, Sills MN, Kremers M, Buja LM, Durant‐Reville M: Regional cardiac adrenergic function using I‐123‐metaiodobenzylguanidine tomographic imaging after acute myocardial infarction. Am J Cardiol 1991; 67: 236–242 [DOI] [PubMed] [Google Scholar]
  • 295. Henderson EB, Kahn JK, Corbett JR, Jansen DE, Pippin JJ, Kulkarni P, Ugolini V, Akers MS, Hansen C, Buja LM, Parkey RW, Willerson JT: Abnormal 1–123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988; 78: 1192–1199 [DOI] [PubMed] [Google Scholar]
  • 296. Glowniak JV, Turner FE, Gray LL, Palac RT, Lagunas‐Solar MC, Woodward WR: Iodine‐123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. J Nucl Med 1989; 30: 1182–1191 [PubMed] [Google Scholar]
  • 297. Gohl K, Feistel H, Weikl A, Bachmann K, Wolf F: Congenital myocardial sympathetic dysinnervation (CMSD): A structural defect of idiopathic long QT syndrome. PACE 1991; 14: 1544–1553 [DOI] [PubMed] [Google Scholar]
  • 298. Mitrani RD, Klein LS, Miles WM, Hackett FK, Burt RW, Wellman HN, Zipes DP: Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease. J Am Coll Cardiol 1993; 22: 1344–1353 [DOI] [PubMed] [Google Scholar]
  • 299. Chidsey CA, Kaiser GA, Sonnenblick EH, Spann JF, Braunwald E: Cardiac norepinephrine stores in experimental heart failure in the dog. J Clin Invest 1964; 43: 2386–2393 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 300. Chidsey CA, Braunwald E, Morrow AG: Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure. Am J Med 1965; 39: 442–451 [DOI] [PubMed] [Google Scholar]
  • 301. Chidsey CA, Sonnenblick EH, Morrow AG, Braunwald E: Norepinephrine stores and contractile force of papillary muscle from the failing human heart. Circulation 1966; 33: 43–51 [DOI] [PubMed] [Google Scholar]
  • 302. Bristow MR, Ginsburg R, Minobe W, Gubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB: Decreased catecholamine sensitivity and b̃‐adrenergic‐receptor density in failing human hearts. N Engl J Med 1982; 307: 205–211 [DOI] [PubMed] [Google Scholar]
  • 303. Anderson FL, Port JD, Reid BB, Larrabee P, Hanson G, Bristow MR: Myocardial catecholamine and neuropeptide Y depletion in failing ventricles of patients with idiopathic dilated cardiomyopathy: Correlation with b̃‐adrenergic receptor downregulation. Circulation 1992; 85: 46–53 [DOI] [PubMed] [Google Scholar]
  • 304. Bobik A, Campbell JH, Carson V, Campbell GR: Mechanism of isoprenaline‐induced refractoriness of the b̃‐adrenoceptor‐adenylate cyclase system in chick embryo cardiac cells. J Cardiovasc Pharmacol 1981; 3: 541–553 [DOI] [PubMed] [Google Scholar]
  • 305. Fishman PH, Mallorga P, Tallman JF: Catecholamine‐induced desensitization of adenylate cyclase in rat glioma C6 cells. Mol Pharmacol 1981; 20: 310–318 [PubMed] [Google Scholar]
  • 306. Schwarz F, Mall G, Zebe H, Blickle J, Derks H, Manthey J, Kübler W: Quantitative morphologic findings of the myocardium in idiopathic dilated cardiomyopathy. Am J Cardiol 1983; 51: 501–506 [DOI] [PubMed] [Google Scholar]
  • 307. Ferrans VJ, Hibbs RG, Black WC, Weinbaecher DG: Isoproterenol‐induced myocardial necrosis. A histochemical and electron microscopic study. Am Heart J 1964; 68: 71–90 [DOI] [PubMed] [Google Scholar]
  • 308. Ostadal B, Rychterova V, Poupa O: Isoproterenol‐induced acute experimental cardiac necrosis in the turtle. (Testudo Horsfieldi) Am Heart J 1968; 76: 645–649 [DOI] [PubMed] [Google Scholar]
  • 309. Schenk EA, Moss AJ: Cardiovascular effects of sustained norepinephrine infusions. II. Morphology. Circ Res 1966; 18: 605–615 [DOI] [PubMed] [Google Scholar]
  • 310. The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis : Disease of the Heart and Blood Vessels, 6th ed., p. 110–114. New York: New York Heart Association/Little, Brown and Company, 1964. [Google Scholar]
  • 311. Brandenburg RO, Chazov E, Falase AO, Grosgogeat Y, Kawai C, Judez M, Orinius E, Goodwin JF, Olsen EGJ, Oakley CM, Pisa Z: Report of the WHO/ISFC task force on definition and classification of cardiomyopathies. Circulation 1981; 64: 437A–438A 7196300 [Google Scholar]
  • 312. Edwards WD: Pathology of endomyocardial biopsy In Pathology of the Heart and Great Vessels (Ed. Waller BF.), p. 191–275. New York: Churchill Livingstone, 1988. [Google Scholar]
  • 313. O'Connell JB, Silver MA: Cardiac disease diagnoses by endomyocardial biopsy In Pathology of the Heart and Great Vessels (Ed. Waller BF.), p. 277–291. New York: Churchill Livingstone, 1988. [Google Scholar]
  • 314. Edwards WD: Endomyocardial biopsy and cardiomyopathy. Cardiovasc Rev Rep 1983; 4: 820–851 [Google Scholar]
  • 315. Dae MW, Marco TD, Botvinick EH, O'Connell JW, Hattner RS, Huberty JP, Yuen‐Green MS: Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts: Implication for clinical studies. J Nucl Med 1992; 33: 1444–1450 [PubMed] [Google Scholar]
  • 316. Yamakado K, Takeda K, Kitano T, Nakagawa T, Futagami Y, Konishi T, Hamada M, Nakano T, Ichihara T: Serial change of iodine‐123 metaiodobenzylguanidine myocardial concentration in patients with dilated cardiomyopathy. Eur J Nucl Med 1992; 19: 265–270 [DOI] [PubMed] [Google Scholar]
  • 317. Yamamoto T, Furutani Y, Katayama K, Harada M, Ichioka T, Fujii T, Matszaki M: A case of dilated cardiomyopathy in which the effects of beta‐blocker therapy were clearly demonstrated by 123–MIBG scintigraphy. Respir Circ 1994; 42: 989–993 (in Japanese with English abstract) [Google Scholar]
  • 318. Heilbrunn SM, Shah P, Bristow MR, Valantine HA, Ginsburg R, Fowler MB: Increased b̃‐receptor density and improved hemodynamics response to catecholamine stimulation during long‐term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 1989; 79: 483–490 [DOI] [PubMed] [Google Scholar]
  • 319. Anderson JL, Gillbert EM, O'Connell JB, Renlund D, Yanowitz F, Murray M: Long‐term (2 years) beneficial effects of beta‐adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1991; 71: 1373–1381 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES